MARKET

INGN

INGN

Inogen
NASDAQ

Real-time Quotes | Nasdaq Last Sale

46.75
+0.33
+0.71%
After Hours: 46.75 0 0.00% 16:01 09/21 EDT
OPEN
47.00
PREV CLOSE
46.42
HIGH
48.05
LOW
46.53
VOLUME
192.92K
TURNOVER
--
52 WEEK HIGH
82.35
52 WEEK LOW
26.90
MARKET CAP
1.06B
P/E (TTM)
-391.2134
1D
5D
1M
3M
1Y
5Y
Here's Why You Should Retain Inogen (INGN) Stock For Now
Investors continue to be optimistic about Inogen (INGN) on its potential in the POC space and a strong product portfolio.
Zacks · 15h ago
BRIEF-Inogen Strengthens Commercial Capabilities Through New Ashfield Relationship
reuters.com · 19h ago
Insider Sell: Inogen
MT Newswires · 4d ago
48 Biggest Movers From Yesterday
Gainers
Benzinga · 09/10 09:16
INGN, MTEX and AVCT among mid-day movers
Gainers: Gevo (NASDAQ:GEVO) +35%. American Virtual Cloud Technologies (NASDAQ:AVCT) +33%. Rocket Lab (NASDAQ:RKLB) +32%. Torrid (NYSE:CURV) +30%. Montauk (NASDAQ:MNTK) +25%. Impel (NASDAQ:IMPL) +22%. Gold Royalty (NYSE:GROY) +22%. ProQR (NASDAQ:PRQR) +21%.
Seekingalpha · 09/09 17:00
ProQR Therapeutics, Centessa Pharmaceuticals leads healthcare gainers; Humanigen, Invacare among major losers
Gainers: ProQR Therapeutics (NASDAQ:PRQR) +22%, Centessa Pharmaceuticals (NASDAQ:CNTA) +22%, Kiromic BioPharma (NASDAQ:KRBP) +19%, Trinity Biotech (NASDAQ:TRIB) +16%, Enveric Biosciences (NASDAQ:ENVB) +14%. Losers: Humanigen (NASDAQ:HGEN) -54%, Invacare (N...
Seekingalpha · 09/09 14:59
Pear and Thimble Point Announce Nominees to Board of Directors
Pear Therapeutics, Inc. ("Pear"), the leader in developing and commercializing prescription digital therapeutics ("PDTs") to treat serious disease, and Thimble Point Acquisition Corp. (Nasdaq: THMA) today announced that Kirthiga Reddy and Alison Bauerlein ...
Business Wire · 09/09 12:35
Inogen (INGN) Shareholder Litigation Alert: Should Inogen Management be Held Accountable for Investors Losses? Contact Johnson Fistel, LLP Regarding Pending Derivative Case
SAN DIEGO, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP, the court-appointed Lead Counsel in a derivative action brought for the benefit of Inogen, Inc. (NASDAQ: INGN) and its shareholders, announces today that a securities fraud class action pen...
GlobeNewswire · 09/02 12:19
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of INGN. Analyze the recent business situations of Inogen through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 6 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average INGN stock price target is 71.00 with a high estimate of 72.00 and a low estimate of 70.00.
EPS
Institutional Holdings
Institutions: 296
Institutional Holdings: 23.78M
% Owned: 105.17%
Shares Outstanding: 22.61M
TypeInstitutionsShares
Increased
59
686.00K
New
33
1.13M
Decreased
50
1.40M
Sold Out
13
220.28K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+0.10%
Healthcare Equipment & Supplies
+0.22%
Key Executives
Non-Executive Chairman/Independent Director
Heath Lukatch
President/Chief Executive Officer/Director
Nabil Shabshab
Co-Founder/Chief Financial Officer/Executive Vice President - Finance/Treasurer/Secretary
Alison Bauerlein
Co-Founder/Executive Vice President
Brenton Taylor
Executive Vice President/General Counsel/Secretary
Jason Somer
Executive Vice President
Stanislav Glezer
Executive Vice President
George Parr
Executive Vice President
Bart Sanford
Director
Elizabeth Mora
Independent Director
Benjamin Anderson-Ray
Independent Director
Raymond Huggenberger
Independent Director
Loren McFarland
Independent Director
Kristen Miranda
Independent Director
Heather Rider
No Data
About INGN
Inogen, Inc. is a medical technology company. The Company develops, manufactures and markets portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The Company's Inogen One systems concentrate the air around the patient to offer a single source of supplemental oxygen anytime, anywhere with a portable device. Its three portable product offerings, the Inogen One G4, Inogen One G3 and Inogen One G2, at approximately 2.8, 4.8 and 7.0 pounds with a single battery, respectively. Its Inogen One G4, Inogen One G3 and Inogen One G2 are sub-3, sub-5 and sub-10 pound portable oxygen concentrators, respectively. All of its Inogen One systems are equipped with Intelligent Delivery Technology. The Inogen At Home stationary oxygen concentrator allows it to access the non-ambulatory oxygen patient market and serves as a backup to its Inogen One system for ambulatory patients on its rental service.

Webull offers kinds of Inogen Inc stock information, including NASDAQ:INGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, INGN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading INGN stock methods without spending real money on the virtual paper trading platform.